Covid 19 And Insurance PDF Download

Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Covid 19 And Insurance PDF full book. Access full book title Covid 19 And Insurance.

Pandemics: Insurance and Social Protection

Pandemics: Insurance and Social Protection
Author: María del Carmen Boado-Penas
Publisher: Springer Nature
Total Pages: 314
Release: 2022
Genre: Applied mathematics
ISBN: 3030783340

Download Pandemics: Insurance and Social Protection Book in PDF, ePub and Kindle

This open access book collects expert contributions on actuarial modelling and related topics, from machine learning to legal aspects, and reflects on possible insurance designs during an epidemic/pandemic. Starting by considering the impulse given by COVID-19 to the insurance industry and to actuarial research, the text covers compartment models, mortality changes during a pandemic, risk-sharing in the presence of low probability events, group testing, compositional data analysis for detecting data inconsistencies, behaviouristic aspects in fighting a pandemic, and insurers' legal problems, amongst others. Concluding with an essay by a practicing actuary on the applicability of the methods proposed, this interdisciplinary book is aimed at actuaries as well as readers with a background in mathematics, economics, statistics, finance, epidemiology, or sociology.


Covid-19 and Insurance

Covid-19 and Insurance
Author: María Luisa Muñoz Paredes
Publisher: Springer Nature
Total Pages: 354
Release: 2023-01-10
Genre: Law
ISBN: 3031137531

Download Covid-19 and Insurance Book in PDF, ePub and Kindle

This book offers a novel study on the impact of the Covid-19 pandemic on insurance from an international and comparative perspective. It assesses how insurance has to adapt to a new landscape, the effects of which will last over time and cut across all areas of the field. To avoid physical contact, digitalisation has accelerated dramatically, affecting insurance in all its phases: risk selection, underwriting, pricing and claims settlement. However, the effects of the Covid-19 pandemic go far beyond that. The extent to which a claim caused directly or indirectly by the virus is or is not covered by a given policy has been the subject of debate in many insurance branches. The most litigated cases worldwide are those that concern damages resulting from business interruption due to restrictions enforced by the authorities in virtually every country. This book analyses the rulings (for and against the insured) that have already been handed down by courts in various jurisdictions (for example in the US, Latin America, Spain and Germany), in order to provide guidance to the parties in future lawsuits and also to guide the courts’ own responses. This analysis extends to the measures that governments have taken in relation to insurance during the pandemic, as well as the changes that insurers have introduced in their general conditions to exclude coverage for the pandemic. This response is unsatisfactory, as the big question is how pandemic-related risks can be covered if private insurers simply refuse to do so. Solutions based on risk sharing with public entities or the use of contractual modalities such as parametric insurance are among those outlined by the authors. The book was written by experts from academia and lawyers specialising in this field, and written for all those interested in the field of insurance: lawyers, judges, academics and legal professionals.


Did COVID-19 Change Life Insurance Offerings?

Did COVID-19 Change Life Insurance Offerings?
Author: Timothy F. Harris
Publisher:
Total Pages: 0
Release: 2020
Genre:
ISBN:

Download Did COVID-19 Change Life Insurance Offerings? Book in PDF, ePub and Kindle

The profitability of life insurance offerings is contingent on accurate projections and pricing of mortality risk. The COVID-19 pandemic created significant uncertainty, with dire mortality predictions from early forecasts resulting in widespread government intervention and greater individual precaution that reduced the projected death toll. We analyze how life insurance companies changed pricing and offerings in response to COVID-19 using monthly data on term life insurance policies from Compulife. We estimate event-study models that exploit well-established variation in the COVID-19 mortality rate based on age and underlying health status. Despite the increase in mortality risk and significant uncertainty, we find limited evidence that life insurance companies increased premiums or decreased policy offerings due to COVID-19.


When Gambling for Resurrection is Too Risky

When Gambling for Resurrection is Too Risky
Author: Divya Kirti
Publisher: International Monetary Fund
Total Pages: 59
Release: 2017-08-07
Genre: Business & Economics
ISBN: 1484314395

Download When Gambling for Resurrection is Too Risky Book in PDF, ePub and Kindle

Rather than taking on more risk, US insurers hit hard by the crisis pulled back from risk taking, relative to insurers not hit as hard by the crisis. Capital requirements alone do not explain this risk reduction: insurers hit hard reduced risk within assets with identical regulatory treatment. State level US insurance regulation makes it unlikely this risk reduction was driven by moral suasion. Other financial institutions also reduce risk after large shocks: the same approach applied to banks yields similar results. My results suggest that, at least in some circumstances, franchise value can dominate, making gambling for resurrection too risky.


Did COVID-19 Change Life Insurance Offerings?

Did COVID-19 Change Life Insurance Offerings?
Author: Timothy F. Harris
Publisher:
Total Pages:
Release: 2020
Genre:
ISBN:

Download Did COVID-19 Change Life Insurance Offerings? Book in PDF, ePub and Kindle

Abstract: The profitability of life insurance offerings is contingent on accurate projections and pricing of mortality risk. The COVID-19 pandemic created significant uncertainty, with dire mortality predictions from early forecasts resulting in widespread government intervention and greater individual precaution that reduced the projected death toll. We analyze how life insurance companies changed pricing and offerings in response to COVID-19 using monthly data on term life insurance policies from Compulife. We estimate event-study models that exploit well-established variation in the COVID-19 mortality rate based on age and underlying health status. Despite the increase in mortality risk and significant uncertainty, we find limited evidence that life insurance companies increased premiums or decreased policy offerings due to COVID-19


A Primer on COVID-19 and Insurance

A Primer on COVID-19 and Insurance
Author: James A. Johnson
Publisher:
Total Pages: 0
Release: 2022
Genre:
ISBN:

Download A Primer on COVID-19 and Insurance Book in PDF, ePub and Kindle

The ongoing coronaviris (COVID-19) pandemic and varients is the most devastating and disruptive forces in recent history. The Covid-19 pandemic will lead to numerous lawsuits involving insurance coverage and commercial disputes. A party whose operations are compromised by the pandemic may have defenses such as impossibility and force majeure.However, the consensus or majority of cases hold that a loss or damage must be caused by a direct and tangible physical injury to the insured property. In most jurisdictions physical loss does not cover a virus because a virus does not result in tangible damage to property. Notwithstanding an argument can be made that the words physical loss could include a business's inability to use the property during the pandemic.To help mitigate the financial crisis created by the Covid-19 pandemic, the federal government has issued guidance relating to employee benefit plan operation and administration.The Coronavirus Aid Relief & Economic Security Act (CARES) provides for substantial financial and administrative relief to participants, sponsors and administrators of certain employee benefit plans. The IRS has clarified and expanded upon the relief offered in the new law.


International Arbitration and the COVID-19 Revolution

International Arbitration and the COVID-19 Revolution
Author: Maxi Scherer
Publisher: Kluwer Law International B.V.
Total Pages: 314
Release: 2020-11-17
Genre: Law
ISBN: 9403528435

Download International Arbitration and the COVID-19 Revolution Book in PDF, ePub and Kindle

International Arbitration and the COVID-19 Revolution Edited by Maxi Scherer, Niuscha Bassiri & Mohamed S. Abdel Wahab The impact of the COVID-19 pandemic on all major economic sectors and industries has triggered profound and systemic changes in international arbitration. Moreover, the fact that entire proceedings are now being conducted remotely constitutes so significant a deviation from the norm as to warrant the designation ‘revolution’. This timely book is the first to describe and analyse how the COVID-19 crisis has redefined arbitral practice, with critical appraisal from well-known practitioners of the pandemic’s effects on substantive and procedural aspects from the commencement of proceedings until the enforcement of the award. With practical guidance from a variety of perspectives – legal, practical, and sector-specific – on the conduct of international arbitration during the COVID-19 pandemic and beyond, the chapters present leading practitioners’ insights into the unprecedented and multifaceted issues that arise. They provide expert tips and challenges in such practical matters as the following: preventing and resolving disputes of particular types – construction, energy, aviation, technology, media and telecommunication, finance and insurance; arbitrator appointments; issues of planning, preparation and sample procedural orders; witness preparation and cross-examination; e-signature of arbitral awards; setting aside and enforcement proceedings; and third-party funding. Also included are an empirical survey of users’ views and an overview of how the COVID-19 revolution has affected the arbitration rules of leading arbitral seats. With this timely and practical book, arbitration practitioners and scholars will gain up-to-date knowledge of sector-specific challenges brought about by the COVID-19 pandemic and approach arbitration proceedings with an understanding of the most important legal and practical considerations during the crisis and beyond.


Framework for Equitable Allocation of COVID-19 Vaccine

Framework for Equitable Allocation of COVID-19 Vaccine
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
Total Pages: 273
Release: 2020-11-30
Genre: Medical
ISBN: 030968224X

Download Framework for Equitable Allocation of COVID-19 Vaccine Book in PDF, ePub and Kindle

In response to the coronavirus disease 2019 (COVID-19) pandemic and the societal disruption it has brought, national governments and the international community have invested billions of dollars and immense amounts of human resources to develop a safe and effective vaccine in an unprecedented time frame. Vaccination against this novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), offers the possibility of significantly reducing severe morbidity and mortality and transmission when deployed alongside other public health strategies and improved therapies. Health equity is intertwined with the impact of COVID-19 and there are certain populations that are at increased risk of severe illness or death from COVID-19. In the United States and worldwide, the pandemic is having a disproportionate impact on people who are already disadvantaged by virtue of their race and ethnicity, age, health status, residence, occupation, socioeconomic condition, or other contributing factors. Framework for Equitable Allocation of COVID-19 Vaccine offers an overarching framework for vaccine allocation to assist policy makers in the domestic and global health communities. Built on widely accepted foundational principles and recognizing the distinctive characteristics of COVID-19, this report's recommendations address the commitments needed to implement equitable allocation policies for COVID-19 vaccine.